NEW YORK, Feb. 26 /PRNewswire-FirstCall/ -- NeoStem, Inc. (Amex: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, today announced that the Company is scheduled to present at the 3rd Annual Stem Cell Summit in New York City on Tuesday, February 26, 2008.
The Annual Stem Cell Summit is organized and produced by RRY Publications and Robin Young Consulting. This year's Summit will feature more than 50 speakers, including a panel of stem cell patients. The goal of the Summit is to bring together investors, industry executives, practitioners and analysts to learn about investment opportunities in the stem cell marketplace, groundbreaking stem cell products physicians are using today, and the growing market potential in terms of revenues. For additional information or to register, please visit http://www.stemcellsummit.com.
Wayne A. Marasco, MD, Ph.D., NeoStem Inc. Cofounder and Chairman of the Scientific Advisory Board will give a brief presentation on the Company's proprietary Very Small Embryonic Like Stem Cells (VSELs) technology. VSELs have been identified in adult bone marrow and resemble embryonic stem cells both morphologically and transcriptionally. Although early stage technology, the Company expects VSELS to serve as the basis for its entry into the therapeutic market place.
VSELs have the ability to grow in the laboratory and multiply into
clusters of cells that then can differentiate into specialized cells found
in different types of tissue including cardiac, neural, endothelial,
muscle, pancreatic and hematopoietic cells. However, unlike controversial
embryonic stem cells,
|SOURCE NeoStem, Inc.|
Copyright©2008 PR Newswire.
All rights reserved